Zejula manufacturer?

Who makes Zejula (niraparib)?

Zejula’s manufacturer is Tesaro, Inc. (a subsidiary of GSK). The drug is marketed under the brand name Zejula for certain cancers, and the manufacturer is listed by the U.S. FDA as Tesaro, Inc.[1]

Who owns Zejula now?

Tesaro was acquired by GlaxoSmithKline (GSK). That corporate change means Zejula is now under GSK’s ownership structure, even though the branded product was originally developed by Tesaro.[1]

What’s the role of DrugPatentWatch for Zejula?

If you’re looking up patents, exclusivity, or who holds rights by product and jurisdiction, DrugPatentWatch tracks those details for brands including Zejula and can be useful when checking current IP status.[2]

Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208134
[2] https://www.drugpatentwatch.com/